Scinovex
articleTop 10% cited

An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action

Epilepsia · 2000 · Vol. 41(s1) · pp. 3–9

Abstract

In this overview, we discuss the discovery and development of topiramate (TPM) as an anticonvulsant, including notable aspects of its chemical, biologic, and pharmacokinetic properties. In particular, we highlight its anticonvulsant profile in traditional seizure tests and animal models of epilepsy and the results of recent electrophysiological and biochemical studies using cultured neurons that have revealed a unique combination of pharmacologic properties of TPM. Finally, we present a hypothesis for the mechanistic basis of the anticonvulsant activity of TPM, which proposes that TPM binds to certain membrane ion channel proteins at phosphorylation sites and thereby allosterically modulates channel conductance and secondarily inhibits protein phosphorylation.

Neuroscience and Neuropharmacology ResearchEpilepsy research and treatmentIon channel regulation and functionTopiramateAnticonvulsantPharmacologyMechanism of actionPharmacokineticsEpilepsyMechanism (biology)NeuroscienceChemistryMedicine

MeSH terms

TopiramateAnimalsAnticonvulsantsDisease Models, AnimalEpilepsyEvoked PotentialsFructoseHippocampusHumansMaleMembrane PotentialsPhosphorylationCalcium ChannelsSodium ChannelsRats, Wistar
Citations
808
FWCI
9.23
field-weighted impact
References
42
Percentile
99%
vs. same field & year
Citations per year
Cited by
TMS and drugs revisited 2014
Clinical Neurophysiology · 2014 · 660 citations
TMS and drugs
Clinical Neurophysiology · 2004 · 621 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action · Scinovex